Multiple esophageal ulcers due to tofacitinib 10 mg twice daily for ulcerative colitis

Clin J Gastroenterol. 2020 Jun;13(3):340-343. doi: 10.1007/s12328-019-01061-y. Epub 2019 Nov 8.

Abstract

A 26-year-old man was admitted to our institution for ulcerative colitis treatment. He used mesalamine, steroid, immunomodulators, and anti-TNFα anti-body, but it was difficult to maintain remission. We started induction therapy with tofacitinib (TOF) 10 mg twice daily. He maintained clinical remission but had chest pain 44 days after the start of TOF. Esophagogastroduodenoscopy showed multiple ulcers from middle to lower esophagus. Although rare, TOF induced esophageal ulcers were considered based on his clinical course and endoscopic findings.

Keywords: Esophageal ulcers; Janus kinase inhibitor; Tofacitinib; Ulcerative colitis.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Colitis, Ulcerative / drug therapy*
  • Esophageal Diseases / chemically induced*
  • Esophageal Diseases / pathology
  • Esophagoscopy
  • Esophagus / pathology
  • Humans
  • Male
  • Piperidines / adverse effects*
  • Piperidines / therapeutic use
  • Protein Kinase Inhibitors / adverse effects*
  • Protein Kinase Inhibitors / therapeutic use
  • Pyrimidines / adverse effects*
  • Pyrimidines / therapeutic use
  • Ulcer / chemically induced*
  • Ulcer / pathology

Substances

  • Piperidines
  • Protein Kinase Inhibitors
  • Pyrimidines
  • tofacitinib